FORBES-TATE

Lobbying for HALOZYME THERAPEUTICS, INC. · U.S. Biotechnology Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income · posted Jan 18, 2026

Lobbying activity 2

Health Issues

Issues related to biopharmaceutical research, development, and manufacturing.

Medicare/Medicaid

Issues related to coverage and reimbursement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.